Cited by — Five-year results of short-course brentuximab vedotin combined with chemotherapy and radiation in early stage, unfavorable Hodgkin lymphoma | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Five-year results of short-course brentuximab vedotin combined with chemotherapy and radiation in early stage, unfavorable Hodgkin lymphoma.
No admitted local citation edges point to this work yet.
